Functional analyses of two novel LRRK2 pathogenic variants in familial Parkinson's disease
Coku, I.; Mutez, E.; Eddarkaoui, S.; Carrier, S.; Marchand, A.; Deldycke, C.; Goveas, L.; Baille, G.; Tir, M.; Magnez, R.; Thuru, X.; Vermeersch, G.; VANDENBERGHE, W.; BUEE, L.; DEFEBVRE, L.; SABLONNIERE, B.; CHARTIER-HARLIN, M.-C.; Taymans, J.-M.; HUIN, V.
Show abstract
BackgroundPathogenic variants in the LRRK2 gene are a common monogenic cause of Parkinsons disease. However, only seven variants have been confirmed to be pathogenic. ObjectivesWe identified two novel LRRK2 variants (H230R and A1440P) and performed functional testing. MethodsWe transiently expressed wildtype, the two new variants, or two known pathogenic mutants (G2019S and R1441G), in HEK-293T cells, with or without LRRK2 kinase inhibitor treatment. We characterized the phosphorylation and kinase activity of the mutants by western blotting. Thermal shift assays were performed to determine the folding and stability of the LRRK2 proteins. ResultsThe two variants were found in two large families and segregate with the disease. They display altered LRRK2 phosphorylation and kinase activity. ConclusionsWe identified two novel LRRK2 variants which segregate with the disease. The results of functional testing lead us to propose these two variants as novel causative mutations for familial Parkinsons disease.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell lines. 93%
- Familial ALS/FTD-associated RNA-Binding deficient TDP-43 mutants cause neuronal and synaptic transcript dysregulation in vitro 91%
- Specific OCRL1 patient mutations differentially impact Lowe Syndrome cellular phenotypes 90%
Similar papers in this journal
Similar papers in this journal
- Large-scale genetic characterization of Parkinson’s disease in the African and African admixed populations 93%
- Genetic modifiers of risk and age at onset in GBA associated Parkinson disease and Lewy body dementia 91%
- Parkinson's disease-related Miro1 mutation induces mitochondrial dysfunction and loss of dopaminergic neurons in vitro and in vivo 91%
Similar papers in this journal
- Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinsons disease 93%
- Dopaminergic Neurodegeneration Induced by Parkinson's Disease-Linked G2019S LRRK2 is Dependent on Kinase and GTPase Activity 93%
- Pleiotropic effects for Parkin and LRRK2 in leprosy type-1 reactions and Parkinson’s disease 91%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.